Skip to main content
Journal of Orthopaedics logoLink to Journal of Orthopaedics
. 2019 Feb 28;16(3):234–240. doi: 10.1016/j.jor.2019.02.022

Association of rs2234693 and rs9340799 polymorphisms of estrogen Receptor-1 gene with radiographic defined knee osteoarthritis: A meta-analysis

Hossein Ahrar a, Kazem Aghili a,, Mohammad Reza Sobhan b, Masoud Mahdinezhad-Yazdi b, Mohammad Javad Akbarian-Bafghi c, Hossein Neamatzadeh d,e
PMCID: PMC6411600  PMID: 30906130

Abstract

Objective

To evaluate the association of ESR1 rs2234693 and rs9340799 polymorphisms with radiographic defined knee osteoarthritis (OA), a case-control and meta-analysis was performed.

Methods

A total of 25 case-control studies with 7,144 cases and 8,468 controls with were included.

Results

There was a significant association between rs2234693 polymorphism and radiographic knee OA under heterozygote model (CT vs. TT: OR = 1.164, 95% CI 1.053–1.286, p = 0.003). However, there was no association between rs9340799 and radiographic knee OA. In subgroup analysis by ethnicity, risk estimates were not augmented.

Conclusions

Our results showed that the ESR1 rs2234693 polymorphism might be associated with radiographic defined knee OA, but not rs9340799.

Keywords: Osteoarthritis, Knee, Radiographic, ESR1 gene, Meta-analysis

1. Introduction

Osteoarthritis (OA) is one of the main causes of functional limitation and reduced quality of life particularly in elderly worldwide.1, 2, 3 Approximately 19% of American adults aged ≤45 years of age experience some symptoms of OA.4 According to the epidemiological studies Asian populations had the highest of knee OA than Caucasians.5 Although the mechanism of OA remains poorly understood, recent findings from molecular epidemiological studies suggest that genetic factors play a strong role in the pathophysiology of OA.6 Moreover, age, ethnicity, gender are systemic risk factors for knee OA.7

Radiography is the most frequently used method for monitoring progression of OA, and useful if surgical intervention is planned or a fracture is suspected. It is allows for an estimation of the space between joints and large bony changes.8 The Kellgren and Lawrence (K/L) system and Osteoarthritis Research Society International (OARSI) atlas are widely used to define the radiographic knee OA. The literature showed a weak correlation between radiographic OA and joint symptoms. Therefore, radiography cannot be used alone to evaluate OA patients.9 Despite limitations, radiography is still remains the main method in epidemiology and research to define and measure OA. In addition, radiography has several advantages including widely available, has better defined outcome measures, takes less time and has a much lower cost.10

A modest but significant genetic effect in modulating the risk of radiographic knee OA has been reported in several studies.6,11 In research settings, several case-control studies on the correlation between rs2234693 and rs9340799 polymorphisms of Estrogen Receptor 1 gene (ESR1) and radiographic defined knee OA had been performed. However, the results remain inconclusive and conflicting. A meta-analysis is a proper method to overcome the problem of small sample sizes and inadequate statistical power in individual studies. Therefore, we conducted this meta-analysis on all previous case-control studies to make a comprehensive and accurate assessment of the associations.

2. Materials and methods

2.1. Case-control study

2.1.1. Subjects

A total of 90 patients with knee OA fulfilled radiographic criteria of OA and American College of Rheumatology (ACR) was recruited to this study between December 2016 and March 2018. Moreover, the control group was composed of 90 matched healthy individuals with no symptoms or signs on clinical examination or radiographic. The protocol for research work was approved by the Human Ethics Committee of Science and Art University and Islamic Azad University, Ashkezar branch, Yazd. Informed written consent was obtained from all the participants before they were enrolled in the study.

2.1.2. Genotyping

DNA was extracted from peripheral blood leukocytes using a commercial DNA Isolation kit following the manufacturer's protocol. The region containing ESR1 rs2234693 and rs9340799 polymorphisms was genotyping by RFLP-PCR assay with the following primers: forward 5′-CTGCCACCCTATCTGTATCTTTTCCTATTCTCC-3′ and 5′-TCTTTCTCTGCCACCCTGGCGTCGATTATCTGA-3’. These polymorphisms have been described at http://www.ncbi.nlm.nih.gov/SNP under identification numbers rs2234693 (c.454-397T > C) and rs9340799 (c.454-351A > G). The intron from the ESR1 gene was amplified by PCR using 50 ng of the genomic DNA in a final reaction volume of 50 μl containing 5 μl of buffer, 0.2 mM dNTPs, 0.2 μM of each primer pair that spanned the polymorphic regions, 2 mM MgSO4, and Taq DNA Polymerase. PCR was carried out in 35 cycles by the following steps: denaturation at 94C for 30 s, annealing at 61C for 40 s, and extension at 37C for 90 s. The PCR products were digested by the PvuII and XbaI restriction endonucleases, respectively. Fragment analysis was performed in 1% agarose gel stained with ethidium bromide, and the bands were separated and photographed under ultraviolet light.

2.2. Meta-analysis

2.2.1. Study identification and selection

PubMed, Google Scholar, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Chinese Wanfang Database, and the Chinese VIP databases for eligible studies examined the association between rs2234693 and rs9340799 polymorphisms of ESR1 gene and radiographic knee OA up to August 15, 2018. The following keywords and terms in various combinations were used: (’‘knee osteoarthritis'’ OR ‘‘radiographic knee’‘) AND (’‘estrogen receptor 1″ or ‘‘estrogen receptor-α’’ OR ‘‘ESR-alpha’’ OR ‘’ nuclear receptor subfamily 3″ OR ‘‘NR3A1″) AND (’‘rs2234693″ OR ‘‘rs9340799″ OR ‘‘PvuII T > C″ OR ‘‘XbaI A > G ‘‘) AND (’‘intron variant’’ OR “polymorphism”, OR “mutation” OR “variant” OR “gene” OR “genotype” OR “SNP” OR “allele”). In addition, hand searching of the references of eligible studies, reviews and related meta-analyses, and the abstracts presented at relevant conferences were performed to identify potentially relevant studies. If there were multiple reports of the same study or overlapping data only the study with the largest sample sizes or the most recent one should be in the final analysis.

2.2.2. Inclusion and exclusion criteria

The inclusion criteria were as follows: (1) published case-control or cohort studies; (2) evaluated the association between rs2234693 and rs9340799 polymorphisms of ESR1 gene and radiographic knee OA; (3) detailed numbers of genotypes must have been provided to calculate the odds ratio (OR) and the corresponding 95% confidence intervals (95% CIs). The exclusion criteria were as follows: (1) studies on clinical or biochemical defined knee OA or total knee replacement (TKA); (2) studies with insufficient information to calculated pooled ORs; (3) studies without healthy control group; (4) sibling pairs, family and linkage studies; and (5) reviews, abstracts, posters, case reports, comments and animal studies. For studies with overlapping case series, only the most recent one or the largest sample sizes were considered. If studies did not report detailed data, we would get in touch with authors to obtain the relevant information.

2.2.3. Data extraction

Two authors carefully performed the data extraction independently from all the eligible studies. In the case of disagreement, a joint review of the study was completed by discussion. The following details were retrieved from the included studies: ESR1 gene polymorphisms, author's name, publication year, country where the study was conducted, ethnicity (categorized as Asian, Caucasian, or mixed), number of patients and control subjects, genotyping methods, source of controls (hospital based or population based), numbers of case and control patients in each genotype, minor allele frequencies (MAFs) in control subjects and Hardy–Weinberg equilibrium (HWE) of genotype distribution.

2.2.4. Statistical analysis

Pooled odds ratio (OR) with corresponding 95% confidence interval (CI) were calculated to estimate the strength of association between rs2234693 and rs9340799 polymorphisms of ESR1 gene and radiographic knee OA risk. The significance of the pooled OR was determined using the Z-test and P < 0.05 was considered statistically significant. We have estimated the pooled ORs for ESR1 rs2234693 and rs9340799 polymorphisms under five genetic models i.e., allele (B vs. A), homozygote (BB vs. AA), heterozygote (AB vs. AA), dominant (BB + AB vs. AA), and recessive (BB vs. AA + AB), which the A represents the wild (major allele) and the B represents the mutant (minor allele). Heterogeneity between studies was assessed using Cochran's chi-square-based Q-test, which the p-value <0.05 for the Q-test indicated a lack of heterogeneity across studies. In addition, the I2 value was used to quantify the percentage of variation between studies, in which 0–25% indicated no observed heterogeneity and larger values showed increasing heterogeneity, with 25–50% regarded as low, 50–75% as moderate, and 75–100% as high. Thus, the fixed effects model was used to pool ORs and 95% confidential interval (CI) when there was no significant heterogeneity. Otherwise, the random effects model (the DerSimonian and Laird method) was utilized. A Hardy-Weinberg equilibrium (HWE) test of rs2234693 and rs9340799 polymorphisms in control subjects was tested by the Chi-square test. If P value > 0.05, the genotype distribution of the control group conformed to HWE. Furthermore, to explore the sources of heterogeneity, we conducted subgroup analysis based on ethnicity and HWE status. To validate the reliability and stability of the pooled ORs, sensitivity analysis was utilized by sequentially omitting individual studies each time, as well as by excluding those studies which were not in agreement with HWE. Publication bias was evaluated by visual inspection of symmetry of Begg's funnel plot of log against its standard error (SE) and the degree of asymmetry was tested using Egger's test, in which P < 0.05 was regarded as representative of statistical significance. All the statistical analyses were performed by comprehensive meta-analysis (CMA) version 2.0 software (Biostat, USA). All p values were two sides and less than 0.05 were considered significant.

3. Results

3.1. Case-control study

The genotypes and alleles distribution by cases and healthy subjects are shown in http://cebp.aacrjournals.org/content/13/5/709.long Table 1. The genotype distributions among healthy subjects for both rs2234693 and rs9340799 polymorphisms were consistent with Hardy-Weinberg equilibrium (p > 0.05). However, the ORs and 95% CIs did not showed significant differences in genotypes and alleles frequency distributions between radiographic defined knee OA patients and healthy subjects for both rs2234693 and rs9340799 polymorphisms (p < 0.05)

Table 1.

The genotype and the allele frequencies of ESR1 polymorphisms in patients and controls.

Polymorphism Radiographic knee OA (%) Control (%) OR (95% CI) P-value
rs2234693
Genotypes
TT 30(33.3) 24(26.7) Ref.
TC 42(46.7) 37(41.1) 1.253(0.695–2.260) 0.453
CC 18(20.0) 29(32.2) 0.526(0.266–1.038) 0.064
Allele
T 102(53.7) 85(44.7) 1.462(0.965–2.214) 0.073
C 78(46.3) 95(55.3) 0.684(0.452–1.037) 0.073
rs9340799
Genotypes
AA 51(56.7) 45(50.0) Ref.
AG 28(31.1) 32(35.6) 0.819(0.440–1.523) 0.527
GG 11(12.2) 13(14.4) 0.825(0.348–1.953) 0.661
Allele
A 130(72.2) 122(67.8) 1.236(0.787–1.942) 0.358
G 50(27.8) 58(32.2) 0.809(0.515–1.271) 0.358

OR: Odds Ratio; CI: Confidence Interval.

3.2. Meta-analysis

3.2.1. Study characteristics

Fig. 1 displayed the selection process of this study. A total of 139 articles were identified after an initial search of databases and manual searching. Of these studies, the first screening excluded 55 studies due to duplicates, leaving 84 articles for further selection. After reading titles and abstracts of the remaining studies, 28 articles were excluded for not relevant to ESR1 polymorphisms and radiographic knee OA. Among the remaining 56 studies, 31 articles also were excluded because they were review articles, case reports, explored other diseases instead of radiographic knee OA, did not have sufficient genotype frequencies, and evaluated other polymorphisms of ESR1 gene. Finally, a total of 25 studies in 12 publications with 7,144 cases and 8,468 controls were included in our meta-analysis. The detailed characteristics of the included studies are listed in Table 2. Among these studies, there were 14 studies12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 on rs2234693 polymorphism with 4,084 cases and 4,993 controls, and eleven studies12, 13, 14, 15, 16, 17,19, 20, 21, 22 on rs9340799 polymorphism with 3,060 cases and 3,475 controls. Four publications were written in Chinese and rest was in English. Of 25 case-control studies, 14 were conducted in Asian populations, 14 were conducted in Caucasian populations, and two were in mixed populations. By source of controls, all studies were population-based (PB) except for one study which not applicable. Two genotyping methods were applied including PCR-RFLP and TaqMan Genotyping Assay. In addition, Genotype distributions in the controls of all the eligible studies were in agreement with HWE, except one study on rs9340799 (Table 2).

Fig. 1.

Fig. 1

Flow diagram of the study selection process.

Table 2.

Main characteristics of studies included in this meta-analysis.

First Author
Country (Ethnicity)
Genotyping
Method
SOC
Case/Control
Cases
Controls
MAFs
HWE
Genotypes
Allele
Genotypes
Allele
rs2234693 TT CT CC T C TT CT CC T C
Bergink 200312 Netherlands(Caucasian) PCR-RFLP PB 1483/687 434 737 312 1605 1361 225 333 129 783 591 0.430 0.767
Xue 200413 China(Asian) PCR-RFLP PB 55/176 17 23 15 57 53 57 87 32 201 151 0.429 0.905
Jin 200414 Korea(Asian) PCR-RFLP PB 151/397 61 68 22 190 112 152 183 62 487 307 0.386 0.575
Yan 200415 China(Asian) PCR-RFLP NA 53/176 10 24 21 44 66 54 82 40 190 162 0.460 0.408
Yang 200916 China(Asian) PCR-RFLP PB 41/40 14 17 10 45 37 12 23 5 47 33 0.412 0.238
Tian 200917 China(Asian) PCR-RFLP PB 38/40 16 15 7 47 29 15 16 9 46 34 0.425 0.250
Rianch 201018 UK (Caucasian) TaqMan PB 445/862 77 245 123 399 491 167 442 253 776 948 0.549 0.292
Spain(Caucasian) 272/802 53 140 79 246 298 179 394 229 752 852 0.531 0.699
Spain(Caucasian) 254/473 46 143 65 235 273 80 217 176 377 569 0.601 0.349
Borgonio-Cuadra 201219 Mexico(Mixed) PCR-RFLP PB 115/117 52 49 14 153 77 51 50 16 152 82 0.350 0.507
Liu 201420 China(Asian) PCR-RFLP PB 98/196 30 41 27 101 95 63 97 36 223 169 0.431 0.900
Dai 201421 China(Asian) TaqMan PB 469/514 167 217 85 551 387 198 242 74 638 390 0.379 0.996
Feng 201722 China(Asian) PCR-RFLP PB 520/1042 260 209 51 729 311 665 327 50 1657 427 0.204 0.234
Present 2018
Iran(Asian)
PCR-RFLP
PB
90/90
30
42
18
102
78
24
37
29
85
95
0.527
0.096
rs9340799




AA
GA
GG
A
G
AA
GA
GG
A
G


Bergink 200312 Netherlands(Caucasian) PCR-RFLP PB 1483/687 643 682 158 1968 998 372 263 52 1007 367 0.267 0.560
Xue 200413 China(Asian) PCR-RFLP PB 55/176 21 24 10 66 44 40 82 54 162 190 0.539 0.408
Jin 200414 Korea(Asian) PCR-RFLP PB 151/397 98 49 4 245 57 256 126 15 638 156 0.196 0.917
Yan 200415 China(Asian) PCR-RFLP NA 55/176 15 23 17 53 57 32 87 57 151 201 0.571 0.905
Yang 200916 China(Asian) PCR-RFLP PB 41/40 28 11 2 67 15 24 13 3 61 19 0.237 0.516
Tian 200917 China(Asian) PCR-RFLP PB 38/40 18 16 4 52 24 6 21 13 33 47 0.587 0.598
Borgonio-Cuadra 201219 Mexico(Mixed) PCR-RFLP PB 115/117 70 41 4 181 49 62 47 8 171 63 0.269 0.821
Liu 201420 China(Asian) PCR-RFLP PB 98/196 36 43 19 115 81 49 92 55 190 202 0.515 0.398
Dai 201421 China(Asian) TaqMan PB 469/514 288 152 29 728 210 348 155 19 851 193 0.184 0.736
Feng 201722 China(Asian) PCR-RFLP PB 520/1042 276 201 43 796 818 618 366 58 1660 1388 0.666 ≤0.001
Present 2018 Iran(Asian) PCR-RFLP PB 90/90 51 28 11 130 50 45 32 13 122 58 0.322 0.077

PCR–RFLP: polymerase chain reaction restriction fragment length polymorphism; PB: population based; NA: not applicable; SOC: source of controls; MAFs: minor allele frequencies; HWE: Hardy-Weinberg Equilibrium.

3.2.2. Quantitative synthesis

Table 3 listed the main results of the meta-analysis of rs2234693 and rs9340799 polymorphisms of ESR1 gene and radiographic knee OA risk. No association was observed in the rs2234693 polymorphism under the dominant model, but there was a significant difference under the heterozygote model (CT vs. TT: OR = 1.164, 95% CI 1.053–1.286, p = 0.003, Fig. 2). By subgroup analysis, we did not find that the rs2234693 polymorphism increased the risk of radiographic knee OA in Asian and Caucasian populations (Table 3). Moreover, when all eleven eligible case-control studies were pooled into the meta-analysis of rs9340799 polymorphism, we not found a significant association between rs9340799 polymorphism and knee OA under all five genetic models, even in the subgroup analyses by ethnicity (Table 3).

Table 3.

Results of the association of ESR1 polymorphisms with radiographic knee OA risk.

Subgroup Genetic Model Type of Model Heterogeneity
Odds Ratio
Publication Bias
I2 (%) PH OR 95% CI Ztest POR PBeggs PEggers
rs2234693 (n=14) C vs. T Random 77.97 ≤0.001 1.067 0.921–1.236 0.866 0.386 0.912 0.521
CC vs. TT Random 69.44 ≤0.001 1.158 0.892–1.504 1.100 0.271 0.912 0.638
CT vs. TT Fixed 26.70 0.168 1.164 1.053–1.286 2.961 0.003 0.100 0.060
CC + CT vs. TT Random 56.64 0.005 1.113 0.945–1.310 1.279 0.201 0.324 0.105
CC vs. CT + TT Random 73.70 ≤0.001 1.110 0.876–1.406 0.861 0.389 0.661 0.683
Ethnicity
Asian (n=9) C vs. T Random 80.53 ≤0.001 1.126 0.881–1.439 0.951 0.342 0.602 0.306
CC vs. TT Random 74.38 ≤0.001 1.282 0.821–2.000 1.093 0.274 0.916 0.424
CT vs. TT Random 51.84 0.034 1.050 0.821–1.343 0.386 0.699 0.916 0.056
CC + CT vs. TT Random 69.93 0.001 1.095 0.818–1.466 0.611 0.541 0.916 0.163
CC vs. CT + TT Random 70.98 0.001 1.307 0.901–1.895 1.409 0.916 0.916 0.632
Caucasian (n=4) C vs. T Random 65.99 0.032 0.997 0.860–1.156 −0.039 0.969 0.308 0.204
CC vs. TT Fixed 52.37 0.098 1.081 0.911–1.283 0.888 0.374 0.308 0.190
CT vs. TT Fixed 0.00 0.913 1.150 0.993–1.330 1.868 0.062 0.734 0.680
CC + CT vs. TT Fixed 0.00 0.739 1.139 0.992–1.307 1.841 0.066 0.308 0.338
CC vs. CT + TT Random 73.23 0.011 0.906 0.693–1.185 −0.720 0.472 0.308 0.192
rs9340799 (n=11)
Asian (n=9) G vs. A Random 87.08 ≤0.001 0.915 0.705–1.187 −0.671 0.502 0.096 0.002
GG vs. AA Random 76.01 ≤0.001 0.792 0.497–1.260 −0.985 0.325 0.061 0.007
GA vs. AA Random 66.35 0.001 0.942 0.749–1.185 −0.512 0.609 0.008 ≤0.001
GG + GA vs. AA Random 77.09 ≤0.001 0.882 0.680–1.143 −0.949 0.343 0.005 ≤0.001
GG vs. GA + AA Random 58.36 0.008 0.944 0.928–1.195 −0.437 0.662 0.042 0.018
G vs. A Random 88.28 ≤0.001 0.870 0.619–1.223 −0.802 0.423 0.173 0.005
GG vs. AA Random 74.84 ≤0.001 0.722 0.416–1.255 −1.155 0.248 0.251 0.052
GA vs. AA Random 56.20 0.019 0.885 0.686–1.141 −0.944 0.345 0.028 0.003
GG + GA vs. AA Random 72.05 ≤0.001 0.817 0.607–1.101 −1.326 0.185 0.028 0.003
GG vs. GA + AA Random 58.07 0.014 0.877 0.590–1.302 −0.653 0.514 0.175 0.097
Fig. 2.

Fig. 2

Forest plots describing the association of ESR1 rs2234693 polymorphism and radiographic knee OA under the heterozygote model (CT vs. TT).

3.2.3. Heterogeneity analysis

For both rs2234693 and rs9340799 polymorphisms of ESR1 gene, significant heterogeneity was found under all five genetic models (Table 3). Therefore, we tested the source of heterogeneity by subgroup analysis based on ethnicity, genotyping methods and HWE status. As shown in Table 3, the I2 decreased obviously and p-value exceeded 0.05 among Caucasian populations in the three genetic models, indicating that ethnicity might be contributed to substantial heterogeneity for rs2234693 in this meta-analysis (Table 3). However, the subgroup analysis for rs9340799 indicated that ethnicity, genotyping methods and HWE status did not responsible for heterogeneity (Table 3).

3.2.4. Sensitivity analysis

Sensitivity analysis was performed to test the influence of individual studies on the pooled ORs of ESR1 rs2234693 and rs9340799 polymorphisms by omitting each study. However, elimination of each study made no qualitative difference on the pooled ORs. In addition, to testify the impact of HWE-violating studies on pooled ORs, sensitivity analysis was performed by excluding those studies. However, the statistical significance of the results did not change, which indicated that our results were stable.

3.2.5. Publication bias

The publication bias of the included studies was assessed by the Funnel plot and Egger's test. The publication bias analysis was shown in Table 3. For rs2234693, shapes of Funnel plot were symmetrical and also the Egger's test provided statistical evidence for the funnel plot symmetry under all five genetic models, suggesting no evidence of publication bias. However, the asymmetric funnel plot and the Egger's test suggested the presence of publication bias for rs9340799 under all five genetic models, i.e., allele model (PBeggs = 0.096 and PEggers = 0.002, Fig. 3A), homozygote (PBeggs = 0.061 and PEggers = 0.007), heterozygote (PBeggs = 0.008 and PEggers≤0.001), dominant (PBeggs = 0.005 and PEggers≤0.001), and recessive (PBeggs = 0.005 and PEggers = 0.018, Fig. 3B) for rs9340799. The existence of publication bias might be a limitation for this meta-analysis because only studies on radiographic knee OA were included. Thus, we applied the Duval and Tweedie non-parametric ‘‘trim and fill’’ method to adjust publication bias results for rs2234693 polymorphism. However, we not observed different results with or without ‘‘trim and fill’’ test, indicating that the current meta-analysis results were statistically robust.

Fig. 3.

Fig. 3

Begg's funnel plots of the ESR1 rs9340799 polymorphism and radiographic knee OA for publication bias test. A: allele model (G vs. A); B: recessive model (GG vs. GA + AA). With (blue) and without (red) ‘‘trim and fill’’ test.

4. Discussion

ESR1 (also known as NR3A1) belong to the nuclear receptor (NR) superfamily of ligand-regulated transcription factors.23,24 Human ER1 gene is located on chromosome 6q25.1, comprises 7 introns and spanning 140 kb.23 Two restriction enzymes defined variants in the first intron of the ESR1 gene have been studied in numerous studies including rs2234693 (PvuII C > T) and rs9340799 (XbaI A > G). The PvuII polymorphism site is located on intron 1, 1400 bps upstream of exon 2, and the XbaI site is approximately 50 bps apart from the PvuII site.25,26

The present meta-analysis was carried out by critically reviewing previous 24 individual case-control studies and the present case-control study on ESR1 rs2234693 and rs9340799 polymorphisms and radiographic knee OA. Our pooled results based on all studies showed that rs2234693 polymorphism was significantly associated with radiographic knee OA, whereas rs9340799 polymorphism was not significantly associated with radiographic knee OA. There was no evidence for the association between rs2234693/rs9340799 polymorphisms and radiographic knee OA in subgroup analyses based on ethnicity. However, considering the limited studies of both rs2234693 and rs9340799 polymorphisms predominately to the Asian populations, our results for subgroup analyses should be interpreted in a conservative manner and need further validation in larger well-designed studies in different ethnicities. For rs2234693, our results are inconsistence with previous meta-analysis. In 2015, Wang et al., performed a meta-analysis of 15 studies to evaluate the possible association between the ESR1 polymorphism and knee OA. Their pooled results suggest that the rs2234693 polymorphism was associated with an increased KOA risk. However, they have not found significant associations between rs2234693 and rs9340799 polymorphisms of ESR1 gene and susceptibility of knee OA by subgroup analyses based on radiographic diagnostic method.27 However, the previous meta-analyses did not cover all eligible studies which could lead to publication bias. Therefore, compared to Wang et al., meta-analysis, the present meta-analysis involved the missed studies, recent published studies and also we performed a case-control study, thus markedly minimizing the selection bias. In addition, we performed subgroup analyses based ethnicity and genotyping methods on radiographic knee OA. Also, these studies showed inconsistent results probably due to different definition of knee OA.

Heterogeneity and publication bias may influence the results of a meta-analysis.28, 29, 30 The heterogeneity might result from age, gender, ethnicity, genotyping methods, sample size, source of controls, life style, and environmental factors.31, 32, 33 In this meta-analysis obvious heterogeneity existed in for both rs2234693 and rs9340799 polymorphisms under all five genetic models. By subgroup analysis, we found the ethnicity was a possible source of heterogeneity for rs2234693. However, the ethnicity did not explain heterogeneity for rs9340799 in this meta-analysis. It is possible that selection of studies limited to radiographic defined knee OA may partially contribute to the high heterogeneity in this meta-analysis.

There were some advantages in the current meta-analysis. First, our study is the most comprehensive and statistically more powerful meta-analysis to investigate the association of ESR1 polymorphisms with the radiographic knee OA than the previous meta-analysis. Second, the patient group was uniformly defined radiographic knee OA and control group was only population-based. Third, the literature search process and data extraction in the meta-analysis was well designed and performed in English and Chinese. Although comprehensive analysis was conducted to show the association of rs2234693 and rs9340799 polymorphisms with radiographic knee OA, there are still some limitations should be pointed out. First, only published articles in English and Chines were included, the unpublished and there may still be some unpublished studies could convert the current meta-analysis pooled ORs. Second, almost all of the included studies are from Asia and a few from Caucasians, and thus, the results were underpowered to address an association by ethnicity. Third, Significant heterogeneity existed in the analysis among two polymorphisms under all five genetic models. However, we have performed subgroup analyses by ethnicity and genotyping methods to clarify sources; it was hard to find all potential sources. Forth, publication bias tests and plots only relevant if > 10 studies are included otherwise underpowered to detect much and tend to lead to conclusions that are not justified, suggesting the reliability of our results. Finally, this meta-analysis was based on unadjusted data, as the ORs adjusted for the main confounding variables such as age, gender, BMI, severity of OA, radiographic grading, life style and environmental factor were not available from those studies.

5. Conclusion

In summary, the current meta-analysis suggested that rs2234693 polymorphism might be associated with radiographic defined knee OA, but not rs9340799 polymorphism. Considering the limitations included in the meta-analysis, further large scale, multicenter, and high-quality studies are necessary to confirm our results.

Conflicts of interest

The authors declare that they have no conflict of interest.

Acknowledgments

We thank all the people who give the help for this study.

References

  • 1.Sobhan M.R., Mehdinejad M., Jamaladini M.H., Mazaheri M., Zare-Shehneh M., Neamatzadeh H. Association between aspartic acid repeat polymorphism of the asporin gene and risk of knee osteoarthritis: a systematic review and meta-analysis. Acta Orthop Traumatol Turcica. 2017;51(5) doi: 10.1016/j.aott.2017.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sobhan M.R., Mahdinezhad-Yazdi M., Aghili K. Association of TNF-α-308 G > A and −238G > A polymorphisms with knee osteoarthritis risk: a case-control study and meta-analysis. J Orthop. 2018;15(3):747–753. doi: 10.1016/j.jor.2018.05.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yazdi M.M., Jamalaldini M.H., Sobhan M.R. Association of ESRα gene Pvu II T > C, XbaI A > G and BtgI G > A polymorphisms with knee osteoarthritis susceptibility: a systematic review and meta-analysis based on 22 case-control studies. ArchE Bone Jt Surg. 2017;(6):5. [PMC free article] [PubMed] [Google Scholar]
  • 4.Wallace I.J., Worthington S., Felson D.T. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017;114(35):9332–9336. doi: 10.1073/pnas.1703856114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Muraki S., Tanaka S., Yoshimura N. Epidemiology of knee osteoarthritis. Sports Med. 2013;1(3):21. [Google Scholar]
  • 6.Aghili K., Sobhan M.R., Mehdinezhad-Yazdi M. Association of GDF-5 rs143383 polymorphism with radiographic defined knee osteoarthritis: a systematic review and meta-analysis. J Orthop. August 2018 doi: 10.1016/j.jor.2018.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–369. doi: 10.1016/j.cger.2010.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115–2126. doi: 10.1016/S0140-6736(11)60243-2. [DOI] [PubMed] [Google Scholar]
  • 9.Bedson J., Croft P.R. The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature. BMC Muscoskelet Disord. 2008;9(1):116. doi: 10.1186/1471-2474-9-116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Guermazi A., Roemer F.W., Burstein D., Hayashi D. Why radiography should no longer be considered a surrogate outcome measure for longitudinal assessment of cartilage in knee osteoarthritis. Arthritis Res Ther. 2011;13(6):247. doi: 10.1186/ar3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jones G., Ding C., Scott F., Cicuttini F. Genetic mechanisms of knee osteoarthritis: a population based case-control study. Ann Rheum Dis. 2004;63(10):1255–1259. doi: 10.1136/ard.2003.015875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bergink A.P., van Meurs J.B., Loughlin J. Estrogen receptor ? gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum. 2003;48(7):1913–1922. doi: 10.1002/art.11046. [DOI] [PubMed] [Google Scholar]
  • 13.Xue Y., Li D., Yao L., Zhou Y., Wang Q., Guo S. Relationship between estrogen receptor gene polymorphism and osteoarthritis in Bei Jing. Chin J Surg. 2005;43:817–818. [Google Scholar]
  • 14.Jin S.-Y., Hong S.-J., In Yang H. Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population. Arthritis Res Ther. 2004;6(5):R415. doi: 10.1186/ar1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yan X., Dong L., Li Y. Relationship of Estrogen receptor polymorphism with osteoarthritis. Chin J Rheumatol. 2004;8:583–586. [Google Scholar]
  • 16.Yang J., Fu S., Xiao F. Case-control study between estrogen receptor gene polymorphisms and osteoarthritis in southern Sichuan high fluoride areas. West China Med J. 2009;24:826–829. [Google Scholar]
  • 17.Tian Z., Guo X., Zhou F., Huang C., Su M., Long X. Study on Relationship between polymorphisms of estrogen-α receptor gene and primary knee osteoarthritis among women in Hunan. Pract Prev Med. 2009;16:1724–1727. [Google Scholar]
  • 18.Riancho J.A., García-Ibarbia C., Gravani A. Common variations in estrogen-related genes are associated with severe large-joint osteoarthritis: a multicenter genetic and functional study. Osteoarthritis Cartilage. 2010;18(7):927–933. doi: 10.1016/j.joca.2010.04.002. [DOI] [PubMed] [Google Scholar]
  • 19.Borgonio-Cuadra V.M., González-Huerta C., Duarte-Salazár C., de los Ángeles Soria-Bastida M., Cortés-González S., Miranda-Duarte A. Analysis of estrogen receptor alpha gene haplotype in Mexican mestizo patients with primary osteoarthritis of the knee. Rheumatol Int. 2012;32(5):1425–1430. doi: 10.1007/s00296-011-1890-2. [DOI] [PubMed] [Google Scholar]
  • 20.Liu W., Shao F.-M., Yan L., Cao H.-X., Qiu D. Polymorphisms in the gene encoding estrogen receptor alpha are associated with osteoarthritis in Han Chinese women. Int J Clin Exp Med. 2014;7(12):5772–5777. http://www.ncbi.nlm.nih.gov/pubmed/25664105 [PMC free article] [PubMed] [Google Scholar]
  • 21.Dai X., Wang C., Dai J. Association of single nucleotide polymorphisms in estrogen receptor alpha gene with susceptibility to knee osteoarthritis: a case-control study in a Chinese Han population. BioMed Res Int. 2014;2014:151457. doi: 10.1155/2014/151457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Feng Z., Wang C., Sun S. Association of estrogen receptor alpha gene polymorphisms and its gene-gene interactions with knee osteoarthritis susceptibility in Chinese Han population. Int J Clin Exp Pathol. 2017;10(5):5971–5977. [Google Scholar]
  • 23.Sobhan M.R., Mahdinezhad-Yazdi M., Jafari M., Mazaheri M., Neamatzadeh H., Daliri K. Association of ESRα XbaI A>G, PvuII T>C and ESRβ AlwNI T>C polymorphisms with the risk of adolescent idiopathic scoliosis: a systematic review and genetic meta-analysis. Rev Bras Ortop. March 2018 doi: 10.1016/j.rboe.2018.03.001. (English Ed. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yazdi M.M., Jamalaldini M.H., Sobhan M.R. Association of ESRα gene Pvu II T>C, XbaI A>G and BtgI G>A polymorphisms with knee osteoarthritis susceptibility: a systematic review and meta-analysis based on 22 case-control studies. Arch Bone Jt Surg. 2017;5(6):351–362. [PMC free article] [PubMed] [Google Scholar]
  • 25.Janusz P., Kotwicki T., Andrusiewicz M., Kotwicka M. XbaI and PvuII polymorphisms of estrogen receptor 1 gene in females with idiopathic scoliosis: No association with occurrence or clinical form. PLoS One. 2013;8(10) doi: 10.1371/journal.pone.0076806. Gonzalez-Alegre P. e76806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gomes-Rochette N.F., Souza L.S., Tommasi B.O. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: effects of aging, body mass index and breast cancer incidence. PLoS One. 2017;12(2) doi: 10.1371/journal.pone.0169266. Cignarella A. e0169266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wang Q., Yan X.-B., Sun Q.-Q., Hu A.-M., Liu H.-L., Yin Y.-W. Genetic polymorphism of the estrogen receptor alpha gene and susceptibility to osteoarthritis: evidence based on 15,022 subjects. Curr Med Res Opin. 2015;31(6):1047–1055. doi: 10.1185/03007995.2015.1037727. [DOI] [PubMed] [Google Scholar]
  • 28.Abedinzadeh M., Zare-Shehneh M., Neamatzadeh H., Abedinzadeh M., Karami H. Association between MTHFR C677T polymorphism and risk of prostate cancer: evidence from 22 studies with 10,832 cases and 11,993 controls. Asian Pac J Cancer Prev APJCP. 2015;16(11) doi: 10.7314/apjcp.2015.16.11.4525. [DOI] [PubMed] [Google Scholar]
  • 29.Mehdinejad M., Sobhan M.R., Mazaheri M., Shehneh M.Z., Neamatzadeh H., Kalantar S.M. Genetic association between ERCC2, NBN, RAD51 gene variants and osteosarcoma risk: a systematic review and meta-analysis. Asian Pac J Cancer Prev APJCP. 2017;18(5) doi: 10.22034/APJCP.2017.18.5.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jafari Nedooshan J., Forat Yazdi M., Neamatzadeh H., Zare Shehneh M., Kargar S., Seddighi N. Genetic association of XRCC1 gene rs1799782, rs25487 and rs25489 polymorphisms with risk of thyroid cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev APJCP. 2017;18(1):263–270. doi: 10.22034/APJCP.2017.18.1.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kamali M., Hantoushzadeh S., Borna S. Association between thrombophilic genes polymorphisms and recurrent pregnancy loss susceptibility in the iranian population: a systematic review and meta-analysis. Iran Biomed J. 2018;22(2) doi: 10.22034/ibj.22.2.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sadeghiyeh T., Hosseini Biouki F., Mazaheri M., Zare-Shehneh M., Neamatzadeh H., Poursharif Z. Association between Catechol-O-Methyltransferase Val158Met (158G/A) polymorphism and suicide susceptibility: a meta-analysis. J Res Health Sci. 2017;17(2) http://www.ncbi.nlm.nih.gov/pubmed/28676589 e00383. [PubMed] [Google Scholar]
  • 33.Kamali M., Hamadani S., Neamatzadeh H. Association of XRCC2 rs3218536 polymorphism with susceptibility of breast and ovarian cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev APJCP. 2017;18(7):1743–1749. doi: 10.22034/APJCP.2017.18.7.1743. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Orthopaedics are provided here courtesy of Elsevier

RESOURCES